China’s recovery from COVID-19 should not tempt us to take the easy way out again
One silver lining of the COVID-19 infection is that policy decisions have been fast tracked
Author
Coping with COVID-19: AGI glaspac
Dealing with hampered production and lack of input raw materials, AGI glaspac has put in measures to cushion the blow. For…
Book Review: The Perfect Pill
Industry veteran Gauri Chaudhari, co-founder, Brand Innerworld gives an in-the-trenches perspective of brand building in her first…
Lessons from COVID-19
Policymakers will have to balance incentives for the pharma sector to scale up production with strict monitoring on environmental…
‘The stereotype that STEM careers are only for men is changing’
Mary Rodgers, virus hunter, principal scientist and head, Abbott Global Surveillance Center explains to Viveka Roychowdhury how…
2019-nCoV, nitrosamine issues trigger supply chain re-jigs
API manufacturers will have to up their quality game to compete with the new competitors The 2019-nCoV infection, which has…
“To end the HIV pandemic, we must continue to outthink this virus”
Mary Rodgers, virus hunter, Principal Scientist and Head, Abbott Global Surveillance Center explains to Viveka Roychowdhury the…
FDAlytics is an intelligent assistant platform to help in GXP
As major pharma companies in India continue to grapple with GMP compliance issues, a startup combining deep learning, AI tech, and…
2019-nCoV must reform India Pharma Inc
Urgent regulatory reform is needed to spur more proactive policies for proposed bulk drug and API parks which will make the…
FDAlytics is an intelligent assistant platform to help in GXP
As major pharma companies in India continue to grapple with GMP compliance issues, a startup combining deep learning, AI tech, and…